ESC Professional Premium Access

Muvalaplin, a Potent Small Molecule Inhibitor of Lipoprotein(a)

Congress Presentation

About the speaker

Professor Stephen Nicholls

Monash University, Melbourne (Australia)
52 presentations
4 followers

3 more presentations in this session

ORION-8: Long-term efficacy and safety of twice-yearly inclisiran in high cardiovascular risk patients

Speaker: Professor R. Wright (Rochester, US)

Thumbnail

LIBerate-HeFH - a novel PCSK9-inhibitor in heterozygous FH

Speaker: Professor F. Raal (Johannesburg, ZA)

Thumbnail

REMAIN-1: A phase 3 study of recaticimab monotherapy in dyslipidaemia

Speaker: Professor J. Ge (Shanghai, CN)

Thumbnail

Access the full session

Late-breaking science on pharmacology

Speakers: Professor S. Nicholls, Professor R. Wright, Professor F. Raal, Professor J. Ge
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb